Concepedia

Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer

Hans W. Nijman, Peter Kenemans, Ria J.J. Poort-Keesom, Rob A. Verstraeten, Sylvia Mensdorff-Pouilly, René H.M. Verheijen, Cornelis J.M. Melief, Jo Hilgers, Chris J.L.M. Meijer

European Journal of Obstetrics & Gynecology and Reproductive Biology · 1999 · 19 citations · 25 references

DOIFull text

Open access

Concepts

References

25

Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer

Dennis J. Slamon, William Godolphin, Lovell A. Jones et al. · Science · 1989 · 6.9K citations

, , +15

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Marc S. Greenblatt, W P Bennett, Monica Hollstein et al. · PubMed · 1994 · 3.5K citations

, , +16

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

Scott W. Lowe, H. Earl Ruley, Tyler Jacks et al. · Cell · 1993 · 2.9K citations

, , +14

Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Steven J. Kuerbitz, Beverly Plunkett, William Walsh et al. · Proceedings of the National Academy of Sciences · 1992 · 1.9K citations

, , +15

Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections

Giorgio Cattoretti, Michael H. G. Becker, Göran Key et al. · The Journal of Pathology · 1992 · 1.5K citations

, , +14